(Q35214728)

7 August 2017

title

Visceral leishmaniasis in lung transplantation (English)

1 reference

7 August 2017

1 reference

visceral leishmaniasis

1 reference

Morales P

1

1 reference

7 August 2017

Torres JJ

2

1 reference

7 August 2017

Salavert M

3

1 reference

7 August 2017

Pemán J

4

1 reference

7 August 2017

Lacruz J

5

1 reference

7 August 2017

Solé A

6

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Transplantation Proceedings

7 August 2017

published in

1 reference

7 August 2017

volume

35

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

2001-2003

1 reference

Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Visceral leishmaniasis in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

HIV-associated visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

1 reference

7 January 2021

Visceral Leishmaniasis in renal transplant recipients: is it still a challenge to the nephrologist?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Fatal visceral leishmaniasis in a heart transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Non-typhoid Salmonella septicemia and visceral leishmaniasis in a renal transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

US Food and Drug Administration Approval of Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis: A Model for Orphan Drug Development

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate—cure with ketoconazole and allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

Oral miltefosine for Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900664-X

7 January 2021

10.1016/S0041-1345(03)00664-X

Identifiers

DOI

1 reference

release_7uzrmclugvhjpevhwrycyvlk74

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7uzrmclugvhjpevhwrycyvlk74

24 November 2022

mapped directly with Wikidata item

1 reference